[Aldosterone blockade in heart failure. So much for so little].
González-Juanatey
José R
JR
Mazón Ramos
Pilar
P
D000368:Aged; D000450:Aldosterone / Q000502:physiology; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D003326:Coronary Circulation; D004232:Diuretics / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D008833:Microcirculation; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D010919:Placebos; D051381:Rats; D011921:Rats, Inbred WKY; D013148:Spironolactone / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D010919:Placebos; D000804:Angiotensin II; D013148:Spironolactone; D000450:Aldosterone
Bloqueo aldosterónico en la insuficiencia cardíaca. Tanto por tan poco.